25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vanta Bioscience Ltd
Buy, Hold or Sell?

Let's analyze Vanta Bioscience Ltd together

I guess you are interested in Vanta Bioscience Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vanta Bioscience Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vanta Bioscience Ltd

I send you an email if I find something interesting about Vanta Bioscience Ltd.

1. Quick Overview

1.1. Quick analysis of Vanta Bioscience Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Vanta Bioscience Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR20.55
Expected worth in 1 year
INR-17.19
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
INR-37.75
Return On Investment
-77.1%

For what price can you sell your share?

Current Price per Share
INR48.98
Expected price per share
INR37.00 - INR75.20
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vanta Bioscience Ltd (5 min.)




Live pricePrice per Share (EOD)
INR48.98
Intrinsic Value Per Share
INR-130.30 - INR175.35
Total Value Per Share
INR-109.74 - INR195.90

2.2. Growth of Vanta Bioscience Ltd (5 min.)




Is Vanta Bioscience Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5m$2.2m-$708.8k-45.9%

How much money is Vanta Bioscience Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$275.5k-$771.2k$495.6k179.8%
Net Profit Margin-23.8%-103.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Vanta Bioscience Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vanta Bioscience Ltd?

Welcome investor! Vanta Bioscience Ltd's management wants to use your money to grow the business. In return you get a share of Vanta Bioscience Ltd.

First you should know what it really means to hold a share of Vanta Bioscience Ltd. And how you can make/lose money.

Speculation

The Price per Share of Vanta Bioscience Ltd is INR48.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vanta Bioscience Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vanta Bioscience Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR20.55. Based on the TTM, the Book Value Change Per Share is INR-9.44 per quarter. Based on the YOY, the Book Value Change Per Share is INR-16.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vanta Bioscience Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.04-0.1%-0.04-0.1%-0.12-0.2%-0.03-0.1%-0.020.0%
Usd Book Value Change Per Share-0.11-0.2%-0.11-0.2%-0.20-0.4%-0.04-0.1%0.040.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-0.2%-0.11-0.2%-0.20-0.4%-0.04-0.1%0.040.1%
Usd Price Per Share0.76-0.76-0.68-0.94-1.09-
Price to Earnings Ratio-17.44--17.44--5.60-198.38-188.42-
Price-to-Total Gains Ratio-6.78--6.78--3.48-17.54-14.86-
Price to Book Ratio3.11-3.11-1.92-2.26-2.58-
Price-to-Total Gains Ratio-6.78--6.78--3.48-17.54-14.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.582862
Number of shares1715
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.11-0.04
Usd Total Gains Per Share-0.11-0.04
Gains per Quarter (1715 shares)-192.59-66.32
Gains per Year (1715 shares)-770.34-265.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-770-7800-265-275
20-1541-15500-531-540
30-2311-23200-796-805
40-3081-30900-1061-1070
50-3852-38600-1326-1335
60-4622-46300-1592-1600
70-5392-54000-1857-1865
80-6163-61700-2122-2130
90-6933-69400-2388-2395
100-7703-77100-2653-2660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vanta Bioscience Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---9.437-9.4370%-16.500+75%-3.250-66%3.426-375%
Book Value Per Share--20.55320.5530%29.990-31%35.467-42%35.689-42%
Current Ratio--0.7500.7500%0.859-13%1.196-37%1.884-60%
Debt To Asset Ratio--0.8480.8480%0.777+9%0.677+25%0.631+34%
Debt To Equity Ratio--4.7654.7650%3.756+27%2.706+76%2.373+101%
Dividend Per Share----0%-0%-0%-0%
Eps---3.669-3.6690%-10.267+180%-2.299-37%-1.732-53%
Free Cash Flow Per Share---1.142-1.1420%-46.446+3968%-19.700+1625%-17.344+1419%
Free Cash Flow To Equity Per Share---1.142-1.1420%-46.446+3968%-19.011+1565%-14.145+1139%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--175.347--------
Intrinsic Value_10Y_min---130.298--------
Intrinsic Value_1Y_max---11.691--------
Intrinsic Value_1Y_min---20.059--------
Intrinsic Value_3Y_max---12.825--------
Intrinsic Value_3Y_min---54.562--------
Intrinsic Value_5Y_max--12.926--------
Intrinsic Value_5Y_min---82.545--------
Market Cap--403968000.000403968000.0000%362940000.000+11%497827440.000-19%575759600.000-30%
Net Profit Margin---0.238-0.2380%-1.033+334%-0.229-4%-0.182-24%
Operating Margin----0%-0%0.045-100%0.072-100%
Operating Ratio--1.4021.4020%1.958-28%1.178+19%1.127+24%
Pb Ratio2.383-31%3.1143.1140%1.917+62%2.263+38%2.579+21%
Pe Ratio-13.350+23%-17.443-17.4430%-5.600-68%198.379-109%188.418-109%
Price Per Share48.980-31%64.00064.0000%57.500+11%78.870-19%91.217-30%
Price To Free Cash Flow Ratio-42.897+23%-56.052-56.0520%-1.238-98%-13.975-75%-16.225-71%
Price To Total Gains Ratio-5.190+23%-6.782-6.7820%-3.485-49%17.540-139%14.863-146%
Quick Ratio--0.1370.1370%0.110+24%0.160-14%0.363-62%
Return On Assets---0.027-0.0270%-0.077+182%-0.015-44%-0.010-65%
Return On Equity---0.152-0.1520%-0.370+143%-0.091-40%-0.071-53%
Total Gains Per Share---9.437-9.4370%-16.500+75%-3.250-66%3.426-375%
Usd Book Value--1543822.7001543822.7000%2252627.755-31%2664022.041-42%2680730.110-42%
Usd Book Value Change Per Share---0.112-0.1120%-0.196+75%-0.039-66%0.041-375%
Usd Book Value Per Share--0.2450.2450%0.357-31%0.422-42%0.425-42%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.044-0.0440%-0.122+180%-0.027-37%-0.021-53%
Usd Free Cash Flow---85763.300-85763.3000%-3488675.400+3968%-1479703.729+1625%-1302778.299+1419%
Usd Free Cash Flow Per Share---0.014-0.0140%-0.553+3968%-0.234+1625%-0.206+1419%
Usd Free Cash Flow To Equity Per Share---0.014-0.0140%-0.553+3968%-0.226+1565%-0.168+1139%
Usd Market Cap--4807219.2004807219.2000%4318986.000+11%5924146.536-19%6851539.240-30%
Usd Price Per Share0.583-31%0.7620.7620%0.684+11%0.939-19%1.085-30%
Usd Profit---275592.100-275592.1000%-771203.300+180%-172653.064-37%-130064.049-53%
Usd Revenue--1157025.1001157025.1000%746832.100+55%1186853.228-3%1235469.521-6%
Usd Total Gains Per Share---0.112-0.1120%-0.196+75%-0.039-66%0.041-375%
 EOD+3 -3MRQTTM+0 -0YOY+23 -95Y+8 -2510Y+8 -25

3.3 Fundamental Score

Let's check the fundamental score of Vanta Bioscience Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.350
Price to Book Ratio (EOD)Between0-12.383
Net Profit Margin (MRQ)Greater than0-0.238
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.137
Current Ratio (MRQ)Greater than10.750
Debt to Asset Ratio (MRQ)Less than10.848
Debt to Equity Ratio (MRQ)Less than14.765
Return on Equity (MRQ)Greater than0.15-0.152
Return on Assets (MRQ)Greater than0.05-0.027
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Vanta Bioscience Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.285
Ma 20Greater thanMa 5046.647
Ma 50Greater thanMa 10045.863
Ma 100Greater thanMa 20049.282
OpenGreater thanClose48.980
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Vanta Bioscience Ltd

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vanta Bioscience Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Vanta Bioscience Ltd to the  industry mean.
  • A Net Profit Margin of -23.8% means that ₹-0.24 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vanta Bioscience Ltd:

  • The MRQ is -23.8%. The company is making a huge loss. -2
  • The TTM is -23.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-23.8%TTM-23.8%0.0%
TTM-23.8%YOY-103.3%+79.4%
TTM-23.8%5Y-22.9%-0.9%
5Y-22.9%10Y-18.2%-4.8%
4.3.1.2. Return on Assets

Shows how efficient Vanta Bioscience Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vanta Bioscience Ltd to the  industry mean.
  • -2.7% Return on Assets means that Vanta Bioscience Ltd generated ₹-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vanta Bioscience Ltd:

  • The MRQ is -2.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.7%TTM-2.7%0.0%
TTM-2.7%YOY-7.7%+4.9%
TTM-2.7%5Y-1.5%-1.2%
5Y-1.5%10Y-1.0%-0.5%
4.3.1.3. Return on Equity

Shows how efficient Vanta Bioscience Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vanta Bioscience Ltd to the  industry mean.
  • -15.2% Return on Equity means Vanta Bioscience Ltd generated ₹-0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vanta Bioscience Ltd:

  • The MRQ is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.2%TTM-15.2%0.0%
TTM-15.2%YOY-37.0%+21.8%
TTM-15.2%5Y-9.1%-6.1%
5Y-9.1%10Y-7.1%-2.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vanta Bioscience Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vanta Bioscience Ltd is operating .

  • Measures how much profit Vanta Bioscience Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vanta Bioscience Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vanta Bioscience Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y4.5%-4.5%
5Y4.5%10Y7.2%-2.7%
4.3.2.2. Operating Ratio

Measures how efficient Vanta Bioscience Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are ₹1.40 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Vanta Bioscience Ltd:

  • The MRQ is 1.402. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.402. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.402TTM1.4020.000
TTM1.402YOY1.958-0.556
TTM1.4025Y1.178+0.223
5Y1.17810Y1.127+0.051
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vanta Bioscience Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vanta Bioscience Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 0.75 means the company has ₹0.75 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Vanta Bioscience Ltd:

  • The MRQ is 0.750. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.750. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.750TTM0.7500.000
TTM0.750YOY0.859-0.109
TTM0.7505Y1.196-0.445
5Y1.19610Y1.884-0.688
4.4.3.2. Quick Ratio

Measures if Vanta Bioscience Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vanta Bioscience Ltd to the  industry mean.
  • A Quick Ratio of 0.14 means the company can pay off ₹0.14 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vanta Bioscience Ltd:

  • The MRQ is 0.137. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.137. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.137TTM0.1370.000
TTM0.137YOY0.110+0.027
TTM0.1375Y0.160-0.023
5Y0.16010Y0.363-0.203
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vanta Bioscience Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vanta Bioscience Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vanta Bioscience Ltd to industry mean.
  • A Debt to Asset Ratio of 0.85 means that Vanta Bioscience Ltd assets are financed with 84.8% credit (debt) and the remaining percentage (100% - 84.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vanta Bioscience Ltd:

  • The MRQ is 0.848. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.848. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.848TTM0.8480.000
TTM0.848YOY0.777+0.072
TTM0.8485Y0.677+0.171
5Y0.67710Y0.631+0.045
4.5.4.2. Debt to Equity Ratio

Measures if Vanta Bioscience Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vanta Bioscience Ltd to the  industry mean.
  • A Debt to Equity ratio of 476.5% means that company has ₹4.77 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vanta Bioscience Ltd:

  • The MRQ is 4.765. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.765. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.765TTM4.7650.000
TTM4.765YOY3.756+1.009
TTM4.7655Y2.706+2.059
5Y2.70610Y2.373+0.333
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Vanta Bioscience Ltd generates.

  • Above 15 is considered overpriced but always compare Vanta Bioscience Ltd to the  industry mean.
  • A PE ratio of -17.44 means the investor is paying ₹-17.44 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vanta Bioscience Ltd:

  • The EOD is -13.350. Based on the earnings, the company is expensive. -2
  • The MRQ is -17.443. Based on the earnings, the company is expensive. -2
  • The TTM is -17.443. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.350MRQ-17.443+4.094
MRQ-17.443TTM-17.4430.000
TTM-17.443YOY-5.600-11.843
TTM-17.4435Y198.379-215.822
5Y198.37910Y188.418+9.961
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vanta Bioscience Ltd:

  • The EOD is -42.897. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -56.052. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -56.052. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-42.897MRQ-56.052+13.155
MRQ-56.052TTM-56.0520.000
TTM-56.052YOY-1.238-54.814
TTM-56.0525Y-13.975-42.077
5Y-13.97510Y-16.225+2.250
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vanta Bioscience Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.11 means the investor is paying ₹3.11 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Vanta Bioscience Ltd:

  • The EOD is 2.383. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.114. Based on the equity, the company is fair priced.
  • The TTM is 3.114. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.383MRQ3.114-0.731
MRQ3.114TTM3.1140.000
TTM3.114YOY1.917+1.197
TTM3.1145Y2.263+0.850
5Y2.26310Y2.579-0.315
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Tax Provision  3,290-1,8811,409-4729378821,819-4,021-2,202



6.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets853,966
Total Liabilities724,233
Total Stockholder Equity151,989
 As reported
Total Liabilities 724,233
Total Stockholder Equity+ 151,989
Total Assets = 853,966

Assets

Total Assets853,966
Total Current Assets171,608
Long-term Assets682,358
Total Current Assets
Cash And Cash Equivalents 1,606
Net Receivables 31,409
Inventory 75,206
Other Current Assets 5,644
Total Current Assets  (as reported)171,608
Total Current Assets  (calculated)113,865
+/- 57,743
Long-term Assets
Property Plant Equipment 284,060
Intangible Assets 382,811
Long-term Assets Other 15,487
Long-term Assets  (as reported)682,358
Long-term Assets  (calculated)682,358
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities228,768
Long-term Liabilities495,465
Total Stockholder Equity151,989
Total Current Liabilities
Short Long Term Debt 121,522
Accounts payable 55,688
Other Current Liabilities 51,558
Total Current Liabilities  (as reported)228,768
Total Current Liabilities  (calculated)228,768
+/-0
Long-term Liabilities
Long term Debt 488,014
Long-term Liabilities Other -2
Long-term Liabilities  (as reported)495,465
Long-term Liabilities  (calculated)488,012
+/- 7,453
Total Stockholder Equity
Total Stockholder Equity (as reported)151,989
Total Stockholder Equity (calculated)0
+/- 151,989
Other
Capital Stock63,120
Common Stock Shares Outstanding 6,312
Net Debt 607,930
Net Invested Capital 761,525
Net Working Capital -57,160
Property Plant and Equipment Gross 284,060



6.3. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-31
> Total Assets 
0
390,005
485,746
696,292
814,040
847,091
853,966
853,966847,091814,040696,292485,746390,0050
   > Total Current Assets 
90,075
170,519
198,461
199,363
144,979
152,429
171,608
171,608152,429144,979199,363198,461170,51990,075
       Cash And Cash Equivalents 
0
32,663
1,951
26,503
2,242
966
1,606
1,6069662,24226,5031,95132,6630
       Short-term Investments 
0
19,500
0
0
0
0
0
0000019,5000
       Net Receivables 
8,166
24,711
33,327
20,149
11,341
19,589
31,409
31,40919,58911,34120,14933,32724,7118,166
       Inventory 
30,244
92,442
140,073
97,642
72,355
71,575
75,206
75,20671,57572,35597,642140,07392,44230,244
       Other Current Assets 
5,435
1,007
22,944
0
7,204
0
5,644
5,64407,204022,9441,0075,435
   > Long-term Assets 
0
219,486
287,286
496,929
669,061
694,662
682,358
682,358694,662669,061496,929287,286219,4860
       Property Plant Equipment 
149,710
167,359
228,987
348,591
373,155
332,294
284,060
284,060332,294373,155348,591228,987167,359149,710
       Intangible Assets 
0
48,623
48,623
138,661
272,744
345,988
382,811
382,811345,988272,744138,66148,62348,6230
       Long-term Assets Other 
0
0
0
0
23,162
-26,652
15,487
15,487-26,65223,1620000
> Total Liabilities 
0
157,713
241,156
434,018
520,596
657,795
724,233
724,233657,795520,596434,018241,156157,7130
   > Total Current Liabilities 
23,962
32,025
98,735
148,431
142,785
177,470
228,768
228,768177,470142,785148,43198,73532,02523,962
       Short Long Term Debt 
0
10,800
37,180
81,335
78,693
100,945
121,522
121,522100,94578,69381,33537,18010,8000
       Accounts payable 
1,943
4,573
4,907
38,467
24,639
42,190
55,688
55,68842,19024,63938,4674,9074,5731,943
       Other Current Liabilities 
3,908
3,085
31,550
4,973
6,165
5,557
51,558
51,5585,5576,1654,97331,5503,0853,908
   > Long-term Liabilities 
0
125,688
142,421
285,588
377,811
480,324
495,465
495,465480,324377,811285,588142,421125,6880
       Other Liabilities 
2,276
4,026
5,907
0
0
0
0
00005,9074,0262,276
> Total Stockholder Equity
0
222,478
234,693
239,188
240,070
175,147
151,989
151,989175,147240,070239,188234,693222,4780
   Retained Earnings 
273
7,238
19,453
23,948
24,830
-40,093
0
0-40,09324,83023,94819,4537,238273
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000



6.4. Balance Sheets

Currency in INR. All numbers in thousands.




6.5. Cash Flows

Currency in INR. All numbers in thousands.




6.6. Income Statements

Currency in INR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue97,229
Cost of Revenue-7,201
Gross Profit90,02890,028
 
Operating Income (+$)
Gross Profit90,028
Operating Expense-129,067
Operating Income-31,838-39,039
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense129,0670
 
Net Interest Income (+$)
Interest Income0
Interest Expense-57,489
Other Finance Cost-0
Net Interest Income-57,489
 
Pretax Income (+$)
Operating Income-31,838
Net Interest Income-57,489
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-88,266-31,838
EBIT - interestExpense = -57,489
-23,159
34,330
Interest Expense57,489
Earnings Before Interest and Taxes (EBIT)0-30,777
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-88,266
Tax Provision--2,202
Net Income From Continuing Ops-86,064-86,064
Net Income-23,159
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net057,489
 

Technical Analysis of Vanta Bioscience Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vanta Bioscience Ltd. The general trend of Vanta Bioscience Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vanta Bioscience Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vanta Bioscience Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 56.00 < 64.84 < 75.20.

The bearish price targets are: 37.28 > 37.01 > 37.00.

Tweet this
Vanta Bioscience Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vanta Bioscience Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vanta Bioscience Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vanta Bioscience Ltd. The current macd is -0.2500798.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vanta Bioscience Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vanta Bioscience Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vanta Bioscience Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vanta Bioscience Ltd Daily Moving Average Convergence/Divergence (MACD) ChartVanta Bioscience Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vanta Bioscience Ltd. The current adx is 20.22.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vanta Bioscience Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vanta Bioscience Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vanta Bioscience Ltd. The current sar is 37.28.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vanta Bioscience Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vanta Bioscience Ltd. The current rsi is 57.28. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Vanta Bioscience Ltd Daily Relative Strength Index (RSI) ChartVanta Bioscience Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vanta Bioscience Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vanta Bioscience Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vanta Bioscience Ltd Daily Stochastic Oscillator ChartVanta Bioscience Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vanta Bioscience Ltd. The current cci is 39.04.

Vanta Bioscience Ltd Daily Commodity Channel Index (CCI) ChartVanta Bioscience Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vanta Bioscience Ltd. The current cmo is 24.32.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vanta Bioscience Ltd Daily Chande Momentum Oscillator (CMO) ChartVanta Bioscience Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vanta Bioscience Ltd. The current willr is -26.50753769.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vanta Bioscience Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vanta Bioscience Ltd Daily Williams %R ChartVanta Bioscience Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vanta Bioscience Ltd.

Vanta Bioscience Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vanta Bioscience Ltd. The current atr is 1.99138783.

Vanta Bioscience Ltd Daily Average True Range (ATR) ChartVanta Bioscience Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vanta Bioscience Ltd. The current obv is 173,250.

Vanta Bioscience Ltd Daily On-Balance Volume (OBV) ChartVanta Bioscience Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vanta Bioscience Ltd. The current mfi is 15.74.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Vanta Bioscience Ltd Daily Money Flow Index (MFI) ChartVanta Bioscience Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vanta Bioscience Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Vanta Bioscience Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vanta Bioscience Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.285
Ma 20Greater thanMa 5046.647
Ma 50Greater thanMa 10045.863
Ma 100Greater thanMa 20049.282
OpenGreater thanClose48.980
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vanta Bioscience Ltd with someone you think should read this too:
  • Are you bullish or bearish on Vanta Bioscience Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vanta Bioscience Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vanta Bioscience Ltd

I send you an email if I find something interesting about Vanta Bioscience Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Vanta Bioscience Ltd.

Receive notifications about Vanta Bioscience Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.